This compound is a pharmaceutical intermediate with a thiazole core and a nitrile-substituted phenol group. Its structure features aromatic rings, an ester functional group, and moderate polarity, indicating potential utility in organic synthesis and drug development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 161798-02-3
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Cis-Octahydro-1H-isoindole hydrochloride
Pharmaceutical intermediate for drug synthesis
Alogliptin Impurity 07
Pharmaceutical impurity reference standard
3-QUINUCLIDINOL
precursor in pharmaceutical synthesis
5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester
Pharmaceutical intermediate
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
Febuxostat
active pharmaceutical ingredient
ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
WTMZFYPEMMFHPR-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)O)C#N)C